glp-1 drug exposure pharmaceutical companies 2025 drugs news What's next for innovation: A primer on the race reshaping pharma and chronic disease care How Pharmacy Plans Are Managing – Top pharmaceuticals of H1 2025:

US$ 22.49

★★★★★ 4.1 (6 reviews)

US$ 20.14

★★★★★ 4.6 (9 reviews)

US$ 29.04

★★★★★ 4.9 (11 reviews)

US$ 21.59

★★★★★ 5.0 (20 reviews)

US$ 22.30

★★★★★ 4.8 (7 reviews)

US$ 21.05

★★★★★ 4.9 (21 reviews)

US$ 26.56

★★★★★ 4.9 (5 reviews)

US$ 27.83

★★★★★ 5.0 (29 reviews)

US$ 29.61

★★★★★ 5.0 (23 reviews)

US$ 28.17

★★★★★ 4.1 (20 reviews)

US$ 27.16

★★★★★ 4.8 (14 reviews)

US$ 21.22

★★★★★ 4.1 (9 reviews)

US$ 25.05

★★★★★ 4.6 (21 reviews)

US$ 23.05

★★★★★ 5.0 (28 reviews)

US$ 26.28

★★★★★ 4.3 (23 reviews)

US$ 22.51

★★★★★ 5.0 (8 reviews)

US$ 20.37

★★★★★ 4.3 (22 reviews)

US$ 23.30

★★★★★ 4.3 (15 reviews)

US$ 20.79

★★★★★ 4.5 (9 reviews)

US$ 29.68

★★★★★ 4.9 (21 reviews)